Kewaunee Scientific financials
$34.00−0.06%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY26 Apr 30 | FY25 Apr 30 | FY24 Apr 30 | FY23 Apr 30 | FY22 Apr 30 | FY21 Apr 30 | FY20 Apr 30 | FY19 Apr 30 | FY18 Apr 30 | FY17 Apr 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $282.0M | $240.5M | $203.8M | $219.5M | $168.9M | $147.5M | $147.5M | $146.6M | $158.1M | $138.6M |
| Gross profit | $80.4M | $68.9M | $52.1M | $35.6M | $24.2M | $24.0M | $23.4M | $25.3M | $32.2M | $26.6M |
| Gross margin | 28.5% | 28.6% | 25.5% | 16.2% | 14.3% | 16.3% | 15.9% | 17.3% | 20.3% | 19.2% |
| Operating income | $16.7M | $17.8M | $18.3M | $5.3M | -$2.3M | -$2.5M | -$2.8M | $1.8M | $9.9M | $6.5M |
| Net income | $9.6M | $11.4M | $18.8M | $738.0K | -$6.1M | -$3.7M | -$4.7M | $1.5M | $5.3M | $4.5M |
| Net margin | 3.4% | 4.7% | 9.2% | 0.3% | −3.6% | −2.5% | −3.2% | 1.0% | 3.3% | 3.3% |
| Diluted EPS | $3.22 | $3.83 | $6.38 | $0.25 | $-2.20 | $-1.33 | $-1.70 | $0.55 | $1.90 | $1.66 |
| EBITDA | $23.6M | $22.7M | $21.4M | $8.2M | $516.0K | $218.0K | -$145.0K | $4.4M | $12.7M | $9.2M |
| Operating cash flow | $18.6M | $14.8M | $19.6M | -$3.8M | -$7.9M | $912.0K | $4.2M | $2.5M | $3.2M | $11.7M |
| Free cash flow | $14.7M | $12.6M | $15.2M | -$7.9M | -$9.8M | -$1.5M | $1.7M | -$1.7M | -$212.0K | $9.1M |
| Diluted shares | 3.0M | 3.0M | 2.9M | 2.9M | 2.8M | 2.8M | 2.8M | 2.8M | 2.8M | 2.7M |
Balance sheet
| Period end | Apr 30 | Apr 30 | Apr 30 | Apr 30 | Apr 30 | Apr 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $9.9M | $14.9M | $23.3M | $8.1M | $4.4M | $5.2M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $46.8M | $65.4M | $31.6M | $32.6M | $31.3M | $6.9M |
| Total assets | $178.3M | $194.7M | $134.8M | $118.9M | $118.8M | $89.4M |
| Total liabilities | $101.5M | $128.4M | $78.6M | $80.4M | $82.6M | $47.9M |
| Shareholders' equity | $76.8M | $66.2M | $56.2M | $38.5M | $36.2M | $41.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology